Filing Details
- Accession Number:
- 0001209191-17-063535
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-04 16:19:01
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-04 16:19:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 57725 | Lannett Co Inc | LCI | Pharmaceutical Preparations (2834) | 230787699 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1262311 | David Farber | 13200 Townsend Road Philadelphia PA 19154 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-01 | 10,000 | $26.88 | 4,191,269 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Farber on November 22, 2017. The 10b5-1 trading plan will allow Mr. Farber to diversify a portion of his holdings consistent with SEC Rule 10b5-1 and the Company's Insider Trading Policy.
Billionaire Hedge Funds
